These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 36998140)
61. Combined expression and prognostic significance of PPFIA1 and ALG3 in head and neck squamous cell carcinoma. Zhou H; Cao T; Li WP; Wu G Mol Biol Rep; 2019 Jun; 46(3):2693-2701. PubMed ID: 30805892 [TBL] [Abstract][Full Text] [Related]
62. Development and validation of a novel survival model for head and neck squamous cell carcinoma based on autophagy-related genes. Ren Z; Zhang L; Ding W; Luo Y; Shi Z; Shrestha B; Kan X; Zhang Z; Ding J; He H; Hu X Genomics; 2021 Jan; 113(1 Pt 2):1166-1175. PubMed ID: 33227411 [TBL] [Abstract][Full Text] [Related]
63. Identification of RNA Modification-Associated Alternative Splicing Signature as an Independent Factor in Head and Neck Squamous Cell Carcinoma. Liu J; Deng W; Xiao Z; Huang X; Lin M; Long Z J Immunol Res; 2022; 2022():8976179. PubMed ID: 36157883 [TBL] [Abstract][Full Text] [Related]
64. Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma. Chi LH; Chang WM; Chang YC; Chan YC; Tai CC; Leung KW; Chen CL; Wu AT; Lai TC; Li YJ; Hsiao M Sci Rep; 2017 Aug; 7(1):9031. PubMed ID: 28831179 [TBL] [Abstract][Full Text] [Related]
65. HtrA3: a promising prognostic biomarker and therapeutic target for head and neck squamous cell carcinoma. Chen Y; Yang J; Jin H; Wen W; Xu Y; Zhang X; Wang Y PeerJ; 2023; 11():e16237. PubMed ID: 37842043 [TBL] [Abstract][Full Text] [Related]
66. DNA methylation biomarkers for head and neck squamous cell carcinoma. Zhou C; Ye M; Ni S; Li Q; Ye D; Li J; Shen Z; Deng H Epigenetics; 2018; 13(4):398-409. PubMed ID: 29927694 [TBL] [Abstract][Full Text] [Related]
68. A transcriptomic map of EGFR-induced epithelial-to-mesenchymal transition identifies prognostic and therapeutic targets for head and neck cancer. Schinke H; Shi E; Lin Z; Quadt T; Kranz G; Zhou J; Wang H; Hess J; Heuer S; Belka C; Zitzelsberger H; Schumacher U; Genduso S; Riecken K; Gao Y; Wu Z; Reichel CA; Walz C; Canis M; Unger K; Baumeister P; Pan M; Gires O Mol Cancer; 2022 Sep; 21(1):178. PubMed ID: 36076232 [TBL] [Abstract][Full Text] [Related]
69. High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma. Li B; Zhu J; Meng L Mol Med Rep; 2019 Feb; 19(2):877-884. PubMed ID: 30535476 [TBL] [Abstract][Full Text] [Related]
70. Analysis of differentially expressed genes in dysplastic oral keratinocyte cell line and their role in the development of HNSCC. Bs A; P A; As SG; A P; J VP J Stomatol Oral Maxillofac Surg; 2024 Sep; 125(4S):101928. PubMed ID: 38815724 [TBL] [Abstract][Full Text] [Related]
71. Identification and Analysis of Senescence-Related Genes in Head and Neck Squamous Cell Carcinoma by a Comprehensive Bioinformatics Approach. Deng L; Mi J; Ruan X; Zhang G; Pan Y; Wang R Mediators Inflamm; 2022; 2022():4007469. PubMed ID: 36299414 [TBL] [Abstract][Full Text] [Related]
72. A Study on the Correlations of the miR-31 Expression with the Pathogenesis and Prognosis of Head and Neck Squamous Cell Carcinoma. Qiang H; Zhan X; Wang W; Cheng Z; Ma S; Jiang C Cancer Biother Radiopharm; 2019 Apr; 34(3):189-195. PubMed ID: 30628842 [TBL] [Abstract][Full Text] [Related]
73. Investigation of miR-21-5p Key Target Genes and Pathways in Head and Neck Squamous Cell Carcinoma Based on TCGA Database and Bioinformatics Analysis. Shen M; Zhou Z; Li BB; Lv M; Feng C; Chen S; Shi S; Kang M; Zhao T Technol Cancer Res Treat; 2022; 21():15330338221081245. PubMed ID: 35235474 [No Abstract] [Full Text] [Related]
74. Transcriptomic analysis reveals key lncRNAs associated with ribosomal biogenesis and epidermis differentiation in head and neck squamous cell carcinoma. Guo YZ; Sun HH; Wang XT; Wang MT J Zhejiang Univ Sci B; 2018 Sept.; 19(9):674-688. PubMed ID: 30178634 [TBL] [Abstract][Full Text] [Related]
75. Chen L; Lin J; Lan B; Xiong J; Wen Y; Chen Y; Chen CB Comput Math Methods Med; 2022; 2022():5851755. PubMed ID: 36510584 [TBL] [Abstract][Full Text] [Related]
76. Co-expression network-based identification of biomarkers correlated with the lymph node metastasis of patients with head and neck squamous cell carcinoma. Jin Y; Qin X Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32076707 [TBL] [Abstract][Full Text] [Related]
77. Identification and in vitro validation of prognostic lncRNA signature in head and neck squamous cell carcinoma. Wang J; Bian Q; Liu J; Moming A Bioengineered; 2021 Dec; 12(2):10049-10062. PubMed ID: 34872450 [TBL] [Abstract][Full Text] [Related]
78. Development and Validation of an Autophagy-Related Signature for Head and Neck Squamous Cell Carcinoma. Liu C; Wu W; Xu M; Mi J; Xu L; Wang R Biomed Res Int; 2021; 2021():1028158. PubMed ID: 34423028 [TBL] [Abstract][Full Text] [Related]
79. Wei Z; Shen Y; Zhou C; Cao Y; Deng H; Shen Z Bioengineered; 2022 May; 13(5):13784-13800. PubMed ID: 35712757 [TBL] [Abstract][Full Text] [Related]
80. High eukaryotic initiation factor 5A2 expression predicts poor prognosis and may participate in the SNHG16/miR-10b-5p/EIF5A2 regulatory axis in head and neck squamous cell carcinoma. Ye S; Wang D; Jin M; Du J; Chen X; Zhang H; Zhou C; Fang S; Liu K J Clin Lab Anal; 2023 Jan; 37(1):e24820. PubMed ID: 36550070 [TBL] [